Literature DB >> 26928715

Unusual metastases of lung cancer: bulbus oculi and maxillary sinus.

I Ates1, O Yazici1, H Ates2, N Ozdemir1, N Zengin1.   

Abstract

Lung adenocarcinoma often makes metastasis to the brain, liver, kidneys, bone, bone marrow and adrenal glands. It can also make metastasis to other parts of the body rarely for example eye, nose, parotid gland and paranasal sinus. We did not encounter with combined ocular bulbus and the maxillary sinus metastases of lung cancer in the accessible literature. In this case report, a patient who was combined ocular bulbus and the maxillary sinus metastases of lung adenocarcinoma will be discussed.

Entities:  

Mesh:

Year:  2015        PMID: 26928715

Source DB:  PubMed          Journal:  Exp Oncol        ISSN: 1812-9269


  5 in total

Review 1.  Jaw bone metastasis from Lung cancer as sole primary source: A systematic review.

Authors:  Sonia Gupta; Manveen-Kaur Jawanda; Aruna Ganganna; Suman Basavaraju; Neha Kashav; Jayata Dhawan; Sumit-Kumar Yadav; Achla-Bharti Yadav
Journal:  J Clin Exp Dent       Date:  2022-07-01

Review 2.  Unusual jaw metastasis from squamous cell lung cancer in heavy smoker: Two case reports and review of the literature.

Authors:  Aldo Pezzuto; Michelangelo Morrone; Elidon Mici
Journal:  Medicine (Baltimore)       Date:  2017-05       Impact factor: 1.889

3.  Huge maxillary metastasis of an aggressive Pancoast tumor -A case report.

Authors:  Ramin Forooghi; Mohammad Ranaei; Fatima Bijani; Safoura Seifi; Daryoosh Moslemi; Mohammadreza Mohammadi; Nima Nikafshar
Journal:  Caspian J Intern Med       Date:  2019

4.  Lung adenocarcinoma metastasis to paranasal sinus: A case report.

Authors:  Wen-Jing Li; Hai-Xiang Xue; Jian-Qiang You; Chang-Jiang Chao
Journal:  World J Clin Cases       Date:  2022-06-16       Impact factor: 1.534

5.  Ocular Metastasis in Elderly Lung Cancer Patients: Potential Risk Factors of CA-125, CA-153 and TPSA.

Authors:  Qian-Min Ge; Yu-Ting Zou; Wen-Qing Shi; Yu-Qing Zhang; Biao Li; You-Lan Min; Qing Yuan; Yi Shao
Journal:  Cancer Manag Res       Date:  2020-03-10       Impact factor: 3.989

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.